Rutika Lifescience Private Limited
About Rutika Lifescience Private Limited
Data last updated:
Rutika Lifescience Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2017PTC302343. Its GSTIN is 27AAICR6449K1ZR (Maharashtra).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kavita Kishor Dhamnaskar and Meghana Kishor Dhamnaskar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat G6/8 S G Barve Nagar Ghatkopar West, Mumbai, Maharashtra, India – 400084.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.2 Lakh, a growth of 133% compared to the previous year. For the same year it recorded a net profit of ₹95,114 (net margin 4.3%) and EBITDA of ₹95,114 (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 55% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat G6/8 S G Barve Nagar Ghatkopar West, Mumbai, Maharashtra, India – 400084
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rutika Lifescience Private Limited
The main business activity of Rutika Lifescience is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rutika Lifescience Private Limited FY 2025 filings available
Rutika Lifescience Private Limited reported revenue of ₹22.2 Lakh (up 133% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Rutika Lifescience Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 55% over five years, including 133% growth in the latest year. EBITDA rose 157% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rutika Lifescience Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹95,114 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹95,114 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rutika Lifescience Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rutika Lifescience are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Rutika Lifescience Private Limited
Rutika Lifescience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anvi Pharmaceuticals Private Limited | ₹22.51 Lakh (FY 2023) | •••• | •••• | -94.0% | •••• | Mumbai, Maharashtra, India |
| Bonton Pharmaceuticals Private Limited | ₹22.4 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Gwalior, Madhya Pradesh, India |
| Gleck Pharma (OPC) Private Limited | ₹22.4 Lakh (FY 2022) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Sukshma Ayurveda Private Limited | ₹22.36 Lakh (FY 2024) | •••• | •••• | 1235.0% | •••• | Satana, Maharashtra, India |
| Aquadry Excipients Private Limited | ₹22.35 Lakh (FY 2019) | •••• | •••• | -77.0% | •••• | Nashik, Maharashtra, India |
| Rutika Lifescience Private Limited this company | ₹22.2 Lakh (FY 2024) | •••• | •••• | 133.0% | •••• | Mumbai, Maharashtra, India |
| Shreeon Pharma Private Limited | ₹22 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Thane, Maharashtra, India |
| Icon Pharma and Surgicals Private Limited | ₹21.94 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Ahmedabad, Gujarat, India |
| Dr. Fin Balor Laboratories Private Limited | ₹21.87 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Bhopal, Madhya Pradesh, India |
| Chickpoul Pharmaceuticals Private Limited | ₹21.79 Lakh (FY 2025) | •••• | •••• | 27.0% | •••• | Samastipur, Bihar, India |
| Mol Chem Limited | ₹21.77 Lakh (FY 2022) | •••• | •••• | -96.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Rutika Lifescience by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Rutika Lifescience Private Limited
Rutika Lifescience has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavita Kishor Dhamnaskar | Director | 01 Dec 2017 | 8 Years 10 Months | Current |
| Meghana Kishor Dhamnaskar | Additional Director | 21 Aug 2020 | 6 Years 1 Months | Current |
| Amit Kishor Dhamnaskar | Additional Director | 21 Aug 2020 | 6 Years 1 Months | Current |
Ownership and Shareholding of Rutika Lifescience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rutika Lifescience Private Limited
Rutika Lifescience Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rutika Lifescience Private Limited
Employment history and EPFO contributions of people linked to Rutika Lifescience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rutika Lifescience Private Limited
Rutika Lifescience Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Amit Kishor Dhamnaskar was appointed as Additional Director on 21 Aug 2020.
Credit Ratings, Litigation & Regulatory Alerts for Rutika Lifescience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rutika Lifescience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rutika Lifescience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rutika Lifescience Private Limited
Rutika Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR6449K1ZR | Maharashtra | Active | 17 Jan 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rutika Lifescience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rutika Lifescience Private Limited
Rutika Lifescience is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2017 (9+ years old) and is registered under CIN U24299MH2017PTC302343.
Rutika Lifescience reported revenue of ₹22.2 Lakh for FY 2024 (up 133% YoY).
Rutika Lifescience has 3 current directors:
- Kavita Kishor Dhamnaskar - Director
- Meghana Kishor Dhamnaskar - Additional Director
- Amit Kishor Dhamnaskar - Additional Director
Rutika Lifescience reported a net profit of ₹95,114 (net margin 4.3%) and EBITDA of ₹95,114 (EBITDA margin 4.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rutika Lifescience is 55% over five years. In the latest year (FY 2024) revenue rose 133%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rutika Lifescience is 27AAICR6449K1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rutika Lifescience is U24299MH2017PTC302343. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rutika Lifescience was incorporated on 01 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rutika Lifescience by revenue are Anvi Pharmaceuticals Private Limited, Bonton Pharmaceuticals Private Limited, Gleck Pharma (OPC) Private Limited, Sukshma Ayurveda Private Limited, Aquadry Excipients Private Limited and 5 more, all in the Pharma industry (Formulations).
Amit Kishor Dhamnaskar was appointed as Additional Director on 21 Aug 2020. Meghana Kishor Dhamnaskar was appointed as Additional Director on 21 Aug 2020. Rutuja Yatin Shelar ceased to be Director on 21 Aug 2020. Rutika Lifescience has 4 board changes on record in total.
The registered office of Rutika Lifescience is at Flat G68 S G Barve Nagar Ghatkopar West, Mumbai, Maharashtra, India – 400084.